Aemetis (NASDAQ:AMTX) Director Sells $20,500.00 in Stock

Aemetis, Inc (NASDAQ:AMTX) Director Timothy Alan Simon sold 10,000 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $2.05, for a total value of $20,500.00. Following the transaction, the director owned 42,632 shares in the company, valued at approximately $87,395.60. This represents a 19.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Aemetis Trading Up 0.3%

NASDAQ AMTX traded up $0.01 on Thursday, hitting $2.02. The company’s stock had a trading volume of 565,171 shares, compared to its average volume of 1,399,658. The firm has a market cap of $141.86 million, a P/E ratio of -1.69 and a beta of 1.36. Aemetis, Inc has a 52-week low of $1.30 and a 52-week high of $3.80. The company’s 50-day simple moving average is $2.60 and its 200 day simple moving average is $2.01.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The company had revenue of $54.62 million during the quarter, compared to the consensus estimate of $66.70 million. On average, research analysts forecast that Aemetis, Inc will post -1.11 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of AMTX. Royal Bank of Canada boosted its stake in Aemetis by 10,632.5% during the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 8,825 shares in the last quarter. Creative Planning purchased a new position in shares of Aemetis during the second quarter valued at approximately $30,000. Virtu Financial LLC purchased a new position in shares of Aemetis during the fourth quarter valued at approximately $31,000. Sanctuary Advisors LLC bought a new stake in shares of Aemetis in the 1st quarter worth approximately $33,000. Finally, HRT Financial LP purchased a new stake in shares of Aemetis in the 4th quarter worth approximately $36,000. 27.02% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Loop Capital set a $1.75 target price on shares of Aemetis in a research report on Thursday, March 12th. Ascendiant Capital Markets increased their price target on shares of Aemetis from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a report on Monday, April 20th. Finally, Wall Street Zen cut Aemetis from a “hold” rating to a “sell” rating in a research report on Saturday, June 6th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $8.92.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.